Podchaser Logo
Home
NEJM This Week — September 28, 2023

NEJM This Week — September 28, 2023

Released Wednesday, 27th September 2023
Good episode? Give it some love!
NEJM This Week — September 28, 2023

NEJM This Week — September 28, 2023

NEJM This Week — September 28, 2023

NEJM This Week — September 28, 2023

Wednesday, 27th September 2023
Good episode? Give it some love!
Rate Episode

Episode Transcript

Transcripts are displayed as originally observed. Some content, including advertisements may have changed.

Use Ctrl + F to search

0:00

Welcome, this is the New England

0:02

Journal of Medicine. I'm Dr.

0:04

Lisa Johnson. This week, September 28,

0:09

2023, we feature articles on anticoagulation

0:12

and atrial high-rate episodes,

0:15

tight blood glucose control in

0:17

patients in the ICU,

0:19

increasing artemisinin-resistant

0:22

malaria in Eritrea, the

0:24

death of a patient after high-dose

0:27

gene therapy, and on

0:29

anti-racist documentation practices,

0:32

a review article on where medical

0:34

statistics meets AI,

0:37

a case report of a woman with confusion,

0:40

and perspective articles on affirmative

0:43

action, population health, and

0:45

hope, on threatening the global

0:47

AIDS response, and on

0:50

swimming. Anticoagulation

0:54

with Adoxaban in Patients

0:56

with Atrial High-Rate Episodes

0:59

by Paulus Kirschhoff from

1:01

the Atrial Fibrillation Network,

1:03

Münster, Germany. Device-detected

1:07

atrial high-rate episodes, AHREs,

1:11

are atrial arrhythmias detected

1:13

by implanted cardiac devices.

1:15

AHREs

1:16

resemble atrial

1:18

fibrillation but are rare and

1:21

brief. Whether the occurrence

1:23

of AHREs in patients

1:26

without atrial fibrillation, as

1:28

documented on a conventional electrocardiogram,

1:31

justifies the initiation of anticoagulants

1:35

is not known.

1:36

In this event-driven trial, 2,536

1:38

patients 65 years of age or older who had

1:40

AHREs lasting for at

1:47

least 6 minutes and who had

1:49

at least one additional risk factor

1:51

for stroke were randomly assigned

1:54

to receive Adoxaban or

1:56

placebo.

1:58

The trial was terminated early.

3:54

there may be several reasons for

3:56

the lack of efficacy of dogs

3:59

First, the trial had inadequate

4:02

statistical power, as the incidence

4:04

of ischemic stroke was only 1%. Second,

4:08

the AHREs that had occurred

4:11

may not have been thrombogenic atrial

4:13

tachyarrhythmias, such as paroxysmal

4:16

atrial fibrillation, but may instead

4:19

have been rhythm disturbances that were

4:21

not expected to substantially impair

4:24

contraction of the left atrial

4:26

appendage. Third, the

4:28

duration and rarity of AHREs

4:31

may have been too brief or too

4:33

infrequent to provoke a left

4:35

atrial thrombus. Although

4:37

AHREs have been associated

4:40

with

4:40

stroke, the risk of stroke remains

4:43

substantially

4:43

less than the risk

4:45

associated with ECG-documented

4:48

paroxysmal or sustained

4:50

atrial fibrillation. The

4:52

lack of efficacy of anticoagulation

4:55

in reducing stroke in the current trial

4:57

may have resulted in part from the

4:59

fact that only a subset of

5:01

the AHREs were thrombogenic,

5:04

namely atrial fibrillation episodes

5:07

of sufficient duration, frequency,

5:09

or both. Future investigation

5:11

may benefit from studying the clinical

5:14

characteristics of populations

5:17

suitable for rhythm monitoring. The

5:19

threshold characteristics of AHREs

5:22

that lead to thrombus formation,

5:24

and the specific atrial tachyarrhythmias

5:27

that occurred during an AHRE

5:29

that could justify anticoagulation.

5:32

However, the device-detected AHREs

5:35

that occurred in this trial do not

5:38

adequately infer a definitive diagnosis

5:41

of paroxysmal atrial fibrillation

5:43

for all patients or a subsequent

5:46

risk of stroke.

5:57

of

6:00

KU Leuven, Belgium. Randomized

6:05

control trials have shown both

6:07

benefit and harm from tight

6:09

blood glucose control in patients

6:12

in the intensive care unit. Variation

6:14

in the use of early parenteral nutrition

6:17

and in insulin-induced severe

6:20

hypoglycemia might explain

6:22

this inconsistency. In

6:25

this study, 9,230 patients were randomly assigned

6:30

upon ICU admission to liberal

6:32

glucose control. Insulin initiated

6:35

only when the blood glucose level was

6:37

greater than 215 milligrams

6:39

per deciliter or to tight

6:42

glucose control. Blood glucose

6:44

level targeted with the use of the

6:46

logic insulin algorithm at 80

6:49

to 110 milligrams per

6:51

deciliter. Parentoral nutrition

6:54

was withheld in both groups

6:56

for the initial week. The

6:58

median morning blood glucose level

7:00

was 140 milligrams per

7:03

deciliter with liberal glucose

7:05

control and 107 milligrams

7:07

per deciliter with tight

7:09

glucose control.

7:11

Severe hypoglycemia occurred

7:13

in 0.7% of patients in

7:16

the liberal control group and in 1%

7:19

of patients in the tight control group.

7:21

The length of time that ICU care

7:24

was needed was similar in the two

7:26

groups. Hazard ratio for earlier

7:28

discharge alive with tight glucose

7:31

control, 1.00. Mortality

7:35

at 90 days was also similar, 10.1% with

7:39

liberal glucose control and 10.5% with

7:41

tight glucose control.

7:44

Analyses of eight pre-specified

7:47

secondary outcomes suggested

7:49

that the incidence of new infections,

7:51

the duration of respiratory and hemodynamics

7:54

support, the time to discharge

7:56

alive from the hospital and mortality

7:59

in the ICU.

10:00

which have acute adverse effects with

10:02

respect to inflammation and oxidative

10:04

stress, neutrophil function, kidney

10:07

function, and hemodynamics. Based

10:10

on evidence from previous randomized

10:12

control trials, the American Diabetes

10:15

Association recommends initiation

10:17

of insulin for the treatment of persistent

10:20

hyperglycemia with a targeted

10:22

glucose range of 140 mg per deciliter

10:24

to 180 mg

10:28

per deciliter for most critically

10:30

ill patients. More stringent

10:32

goals, such as a glucose level of 100

10:35

to 180 mg per

10:37

deciliter, may be appropriate

10:39

as long as they can be achieved without

10:42

clinically significant hypoglycemia.

10:47

Increasing prevalence of artemisinin-resistant

10:51

HRP2-negative malaria

10:53

in Eritrea. By Salam

10:56

Meritib from the Ministry of Health,

10:58

Asmara Eritrea. Although

11:01

the clinical efficacy of anti-malarial

11:05

artemisinin-based combination therapies

11:07

in Africa remains high,

11:10

the recent emergence of partial resistance

11:12

to artemisinin in P. falciparum

11:15

on the continent is troubling given

11:17

the lack of alternative treatments.

11:20

These authors describe the results

11:22

of therapeutic efficacy studies

11:24

conducted between 2016 and 2019 at five sites in

11:27

Eritrea, evaluating three-day

11:32

courses of artemisinin-based

11:35

combination therapy for uncomplicated

11:38

falciparum malaria. The

11:40

authors assess the percentage of patients

11:43

with day three positivity, that

11:45

is, persistent P. falciparum

11:47

parasitemia three days after

11:50

the initiation of therapy, and

11:52

assay parasites for molecular

11:55

signatures of partial resistance

11:57

to artemisinin.

11:59

The authors noted an increase in

12:02

the percentage of patients with day 3

12:04

positivity,

12:05

from 0.4% in 2016

12:07

to 1.9% in 2017 and 4.2% in 2019.

12:15

An increase was also noted in

12:17

the prevalence of the PF-CELCH13R622i

12:22

mutation in P. falciparum

12:24

parasites, which was detected in 109 of 818

12:26

isolates before treatment, from 8.6% in 2016 to 21%

12:34

in 2019. The

12:38

odds of day 3 positivity increased

12:40

by a factor of 6.2 among

12:43

the patients with PF-CELCH13622i variant

12:47

parasites. Physical

12:49

resistance to artemisinin, as

12:51

defined by the World Health Organization,

12:54

was observed in Eritrea.

12:57

More than 5% of the patients younger

12:59

than 15 years of age with day 3

13:02

positivity also had parasites

13:04

that carried PF-CELCH13R622i. Deletions

13:09

in both HRP2 and HRP3,

13:13

which encode histidine-rich

13:15

and alanine-rich proteins, analyzed

13:18

in several cell compartments, including

13:20

the cytoplasm of P. falciparum,

13:23

were identified in 16.9%

13:26

of the parasites that carried the

13:28

PF-CELCH13R622i

13:31

mutation, which made them potentially

13:34

undetectable by HRP2-based

13:37

rapid diagnostic tests. The

13:39

emergence and spread of P. falciparum

13:42

lineages with both PF-CELCH13-mediated

13:46

partial resistance to artemisinin

13:49

and deletions in HRP2 and

13:51

HRP3 in Eritrea threatened to compromise regional

13:56

malaria control and elimination

13:58

campaigns.

14:01

Brian Greenwood from the London

14:03

School of Hygiene and Tropical Medicine

14:05

writes in a perspective article that

14:08

progress in malaria control in

14:10

some countries in sub-Saharan Africa

14:13

is now challenged by several new

14:15

threats. These include colonization

14:18

of parts of the region by the Asian

14:20

mosquito vector Anopheles Stefensi,

14:23

which, unlike the main malaria vectors

14:26

currently responsible for most malaria

14:28

transmission in sub-Saharan Africa,

14:31

thrives in urban settings, increasing

14:33

the risk of malaria in the region's

14:36

large urban centers that are currently

14:38

relatively malaria free. A

14:41

second major threat comes from the

14:43

recent emergence in East Africa

14:45

of P. falciparum parasites with

14:48

reduced susceptibility to artemisinin-based

14:51

combination drugs, the drugs that

14:53

form the mainstay of treatment of

14:55

falciparum malaria. The

14:57

results of the study by Miratib and colleagues

15:00

raise a further issue. The

15:02

investigators identified P.

15:04

falciparum parasites that were

15:07

resistant to artemisinins and

15:09

also had deletions in HRP2,

15:12

HRP3, or both, which

15:14

potentially delay the diagnosis

15:17

and effective treatment of infections

15:19

with an artemisinin-resistant parasite.

15:22

P. falciparum parasites with HRP2

15:25

or HRP3 deletions are

15:28

widely distributed in Eritrea,

15:30

and it is therefore not surprising that

15:33

some parasites with these deletions

15:35

also had the R622i

15:38

mutation associated with resistance.

15:41

It is concerning, however, that the HRP2

15:44

deletion was found three

15:46

times as frequently in parasites

15:49

carrying the R622i mutation

15:52

as in parasites without it. Given

15:55

that the HRP2 and P. falciparum-based

15:57

gene are genetically

15:59

unlinked and are on different

16:02

parasite chromosomes, it is unclear

16:05

how co-selection might operate.

16:08

To counter the threat posed to malaria

16:10

control in sub-Saharan Africa

16:12

by P. falciparum parasites with

16:15

HRP2 or HRP3

16:17

deletions and mutations

16:19

associated with resistance, countries

16:22

must rely first on enhanced

16:25

surveillance to detect these

16:27

parasites. Death

16:30

after high dose RAAV9

16:33

gene therapy in a patient with

16:35

Duchenne's muscular dystrophy by

16:38

Angela Leck from Yale School

16:40

of Medicine, New Haven, Connecticut.

16:44

Duchenne's muscular dystrophy is

16:46

a fatal X-linked myopathy

16:48

caused by mutations in DMD,

16:51

the large structural gene encoding

16:54

dystrophin.

16:56

Dystrophin plays a major role

16:58

in the function of cardiac myocytes

17:01

and skeletal myofibers as

17:03

part of the dystrophin glycoprotein

17:06

complex that anchors myofilaments

17:09

to the extracellular matrix and

17:11

prevents stress-induced damage

17:13

to the sarcolemma membrane.

17:16

Several recombinant adeno-associated

17:18

virus RAAV-based

17:21

approaches to gene therapy for this

17:23

disorder have been developed.

17:26

These authors treated a 27-year-old patient with

17:29

Duchenne's muscular dystrophy with

17:32

recombinant AAV serotype 9

17:35

containing DSA Cas9,

17:37

that is, dead Staphylococcus

17:40

aureus Cas9, in which the

17:42

Cas9 nuclease activity has

17:45

been inactivated,

17:46

fused to VP64.

17:49

This transgene was designed

17:52

to upregulate cortical dystrophin

17:55

as a custom CRISPR transactivator

17:57

therapy.

17:59

The dose of recur-

17:59

the predominant AAV used was 1

18:02

x 10 to the 14th vector

18:05

genomes per kilogram of the patient's body

18:08

weight. Mild cardiac dysfunction

18:10

and pericardial effusion developed,

18:13

followed by acute respiratory distress

18:15

syndrome, ARDS, and

18:17

a cardiac arrest six days

18:20

after transgene treatment. The

18:22

patient was initially resuscitated

18:24

but died two days later. A post-mortem

18:26

examination showed

18:29

severe diffuse alveolar damage.

18:32

Expression of transgene in the liver

18:35

was minimal, and there was no evidence

18:37

of AAV serotype 9 antibodies

18:40

or effector T-cell reactivity

18:42

in the organs. These findings

18:44

indicate that an innate immune

18:47

reaction caused ARDS

18:49

in this patient with advanced Duchenne's

18:52

muscular dystrophy, treated with

18:54

high-dose recombinant AAV

18:57

gene therapy. Where

19:00

Medical Statistics Meets Artificial

19:03

Intelligence, a review article

19:05

by David Hunter from the Nuffield

19:08

Department of Population Health in

19:10

the United Kingdom. In

19:12

the 21st century, artificial

19:15

intelligence has emerged as

19:17

a valuable approach in data

19:19

science and a growing influence

19:21

in medical research with an accelerating

19:24

pace of innovation. This

19:26

development is driven in part

19:29

by the enormous expansion in

19:31

computer power and data availability.

19:34

However, the very features

19:36

that make AI such a valuable

19:39

additional tool for data analysis

19:42

are the same ones that make it vulnerable

19:44

from a statistical perspective.

19:47

This paradox is particularly pertinent for

19:50

medical science. In this review,

19:53

the authors explore three particular

19:56

challenges at the interface of

19:58

statistics and AI. that

20:00

are of particular relevance to

20:02

medical studies, population

20:04

inference versus prediction, generalizability

20:08

and interpretation of evidence, and

20:10

stability and statistical guarantees.

20:14

The authors focus on issues of

20:16

data analysis and interpretation

20:19

of findings.

20:20

Much of the art of

20:21

applied statistics and the skills

20:23

of a trained statistician or epidemiologist

20:27

involve factors that lie outside

20:29

the data and hence cannot

20:32

be captured by data-driven

20:34

AI algorithms alone. These

20:37

factors include careful design

20:39

of experiments, an understanding

20:42

of the research question and study

20:44

objectives, and tailoring of models

20:46

to the research question in the context

20:49

of an existing knowledge base with

20:51

ascertainment and selection bias

20:54

accounted for and a healthy suspicion

20:56

of results that look too good to be true,

20:59

followed by careful model checking.

21:02

Bringing these skills to bear on

21:04

AI-enabled studies through human-in-the-loop

21:08

development in which AI supports

21:10

and assists expert human judgment

21:13

will likely enhance the effect

21:15

and uptake of AI methods

21:18

and highlight methodologic and

21:20

theoretical gaps to be addressed

21:23

for the benefit of medical science.

21:27

A 50-year-old woman with

21:28

confusion,

21:30

a case record of the Massachusetts

21:32

General Hospital by Amulya

21:34

Nagar and colleagues. A

21:38

50-year-old woman was admitted to the hospital

21:41

because of confusion. Rouen-Y

21:43

gastric bypass surgery had been performed 12

21:46

years earlier, five

21:48

months before the current presentation, dysphagia

21:51

developed and the patient began to lose

21:54

weight. Biopsy specimens

21:56

obtained during esophagogastro

21:58

duodenoscopy showed findings

22:01

consistent with lymphocytic esophagitis.

22:04

An attempt at treatment with swallowed

22:06

fluticasone did not increase

22:08

the patient's oral intake. Weight

22:11

loss occurred despite progressive

22:13

leg edema, which was suggestive

22:15

of muscle loss. Two months

22:18

before the current presentation, the

22:20

patient was admitted to the hospital because

22:22

of anasarka. The patient

22:24

had an albumin level of 1.9 grams

22:27

per deciliter. It was hypothesized

22:30

that poor oral intake from lymphocytic

22:33

esophagitis had led to protein

22:35

calorie malnutrition and hypoalbuminemia.

22:39

One week before the current

22:40

admission, the patient had rapidly

22:43

progressive encephalopathy and an

22:45

unsteady gait that resulted in

22:47

a fall. A UTI with Klebsiella

22:50

pneumoniae was diagnosed.

22:52

Hypotension abated after the

22:54

administration of vasopressors and systemic

22:57

antibiotic agents, but altered

22:59

mental status persisted.

23:02

The differential diagnosis for altered

23:04

mental status in this patient was

23:06

broad. However, there is an

23:08

increasingly recognized association

23:11

between non-sorotic hyperaminemia

23:14

and a history of Rouen Y gastric

23:17

bypass. Hyperaminemic

23:19

encephalopathy may develop

23:21

at various points after gastric

23:24

bypass surgery with hallmark

23:26

findings, including hypoalbuminemia,

23:29

nutritional deficiencies, and elevated

23:31

plasma glutamine level and a low

23:34

zinc level. Delays in

23:36

diagnosis and management may

23:38

result in a poor prognosis

23:41

with a high risk of death. In

23:43

this patient, the serum ammonia

23:45

level was 90 micromoles

23:47

per liter and remained elevated

23:50

on repeat measurements with a

23:52

maximum level of 107 micromoles per liter. documentation

24:01

practices, shaping clinical

24:03

encounters and decision-making.

24:06

A perspective by J. Corey Williams

24:09

from Georgetown University, Washington,

24:11

D.C. Clinicians

24:14

receive inconsistent instruction

24:16

on how to use patients' racial

24:18

identities in clinical documentation

24:21

and decision-making and often

24:24

document this information without

24:26

clear reasons or an understanding

24:28

of its relevance. Routine

24:30

documentation of racial categories

24:33

is rooted in the mythology of

24:35

inherent biologic differences

24:38

between racial groups, especially

24:40

between Black and non-Hispanic

24:43

white people. Such

24:45

myths founded on medical racism

24:47

and white supremacist ideology

24:49

have been used to justify historical

24:52

atrocities, including enslavement

24:55

of people of African descent and

24:57

continue to normalize disparate

24:59

treatment of Black and other racially

25:02

minoritized patients by the U.S.

25:05

healthcare system. Documentation

25:08

serves several critical functions,

25:10

recording essential data for clinical care,

25:13

communicating medical decisions, educating

25:16

trainees, and determining reimbursement.

25:19

Documentation of race in patients'

25:22

charts can trigger a cascade

25:24

of effects. Clinicians read

25:26

or copy and paste previous

25:28

notes to inform their understanding of

25:31

a patient's health and illness, and

25:33

they may carry forward any flawed

25:36

discriminatory descriptions, heuristics,

25:39

or beliefs the notes contain. These

25:42

authors recommend adopting documentation

25:44

practices that encourage anti-racism,

25:48

the active process of identifying

25:50

and dismantling racism using

25:53

measures that produce or sustain

25:55

equity among racial groups, including

25:58

changing organizational conditions. structures,

26:01

policies, practices, and

26:03

attitudes. These authors discuss

26:06

conventional medical documentation

26:08

and make recommendations for anti-racist

26:11

changes in approach. Affirmative

26:16

action, population health, and

26:18

the importance of opportunity and

26:20

hope. A perspective by

26:23

Athene Dar Venkataramani from

26:25

the University of Pennsylvania, Philadelphia.

26:29

After several states banned race-based

26:32

affirmative action in university

26:34

admissions, debates over

26:36

affirmative action culminated

26:39

in the Supreme Court's June 2023 decision

26:42

declaring affirmative action in

26:44

undergraduate, graduate, and professional

26:47

education unconstitutional.

26:50

Policy debates related to affirmative

26:53

action have typically focused on its

26:55

effects on education, employment,

26:58

and earnings. However, these debates

27:01

have generally neglected the important

27:03

role affirmative action may play

27:05

in shaping population health.

27:08

There are at least three mechanisms

27:11

by which the use of affirmative action

27:13

in admissions might affect health.

27:16

First, data from California

27:18

show that affirmative action programs

27:21

can have a positive effect on college

27:23

graduation rates and future earnings

27:26

among black, Hispanic, and American

27:28

Indian and Alaska Native students,

27:31

which underscores the value associated

27:34

with having access to selective

27:36

institutions of higher education.

27:39

Second, affirmative action programs

27:41

have important consequences for the

27:43

health care workforce. A lack

27:45

of diversity in the physician workforce

27:47

has implications for population

27:50

health and health equity. And

27:52

a third and less discussed mechanism

27:55

by which affirmative action programs may

27:57

affect health is through the messages

27:59

they have. they send to population

28:01

groups facing structural barriers.

28:04

These programs and their termination can

28:07

signal to young people about their

28:09

prospects for upward mobility, their

28:11

belonging in society, and the degree

28:14

of systemic discrimination they may

28:16

face. Such affective

28:18

consequences, namely the effects

28:20

of policies on hope and beliefs

28:23

about opportunities for upward mobility,

28:26

can meaningfully shape health-related

28:28

behaviors and

28:29

outcomes.

28:32

Threatening the Global AIDS

28:34

Response, Obstacles to

28:37

PEPFAR's Reauthorization,

28:39

a perspective by Salim

28:41

Abdul Karim from the University

28:44

of KwaZulu-Natal, Durban,

28:46

South Africa. The

28:48

U.S. President's Emergency Program

28:51

for AIDS Relief, PEPFAR, the

28:53

largest commitment in history by any

28:55

single country to address a disease,

28:58

is estimated to have averted 25 million

29:02

deaths from AIDS and enabled 5.5 million

29:05

babies to be born free from

29:08

HIV infection over the

29:10

past 20 years.

29:12

It has provided more than $100 billion

29:15

in funding for HIV prevention,

29:18

care, and treatment internationally,

29:21

supporting 55 low- and middle-income

29:23

countries that are collectively home

29:26

to 78% of all

29:28

people living with HIV.

29:31

Since its establishment, PEPFAR

29:34

has had bipartisan support in

29:36

the United States and has been reauthorized

29:39

by both chambers of the U.S.

29:41

Congress three times.

29:43

But several Republican politicians

29:46

are now demanding that reauthorization

29:49

be linked to new prohibitions

29:52

related

29:53

to abortion.

29:54

Some influential anti-abortion

29:57

organizations have

29:58

warned Republican members

29:59

of Congress that voting for the

30:02

reauthorization of PEPFAR without

30:04

abortion-related restrictions would

30:06

negatively affect the ratings these

30:09

organizations give members

30:11

each year, which

30:12

would, in turn, diminish

30:14

their prospects for re-election.

30:17

The lawmakers stalling the reauthorization

30:20

are seeking to impose on PEPFAR

30:22

a prohibition on the disbursement

30:24

of federal funding to foreign agencies

30:27

and non-governmental organizations

30:29

that provide, promote, or make

30:31

referrals to abortion services

30:34

or give information about abortions,

30:36

even if they use funding from sources

30:39

other than the U.S. government to do

30:41

so. These authors discuss

30:44

several reasons to object strenuously

30:47

to the

30:47

proposed restrictions on PEPFAR.

30:50

Its reauthorization should not be

30:52

held hostage to policies about

30:54

health care that are only distantly

30:57

related, if at all, to the primary

30:59

goals of the PEPFAR program.

31:03

Swimming, a perspective by

31:06

Margaret Isaac from the University

31:08

of Washington School of Medicine, Seattle.

31:13

2002, they were standing in the ocean on the Pacific

31:15

coast of Costa Rica. Dr. Isaac

31:18

and her brother, water waist-high,

31:21

hot sun on their faces, sand

31:23

and salt water swirling eddies between

31:25

their toes. Around them,

31:28

the indistinct sound of surf and

31:30

laughter. They were warm, relaxed,

31:33

content. But every so

31:35

often, a moment occurs in which everything

31:38

changes. A point of inflection.

31:41

Eyes blink, a breath is taken, a

31:44

gust ruffles the hair, the landscape

31:46

shifts, and danger makes

31:49

its presence known. In

31:51

this moment in 2002, this

31:53

blink of an eye, they found themselves

31:56

carried beyond the breakers, pulled

31:58

out by a muscular

31:59

riptide for which that beach was

32:02

apparently known.

32:04

The fact that Dr. Isaac barely

32:06

knew how to swim was something she

32:08

was aware of only in a vague sort of way,

32:10

the need for this skill in her daily

32:12

life being virtually non-existent.

32:15

But on that day she found

32:17

herself flailing against a rip

32:19

current, trying her best to paddle

32:22

to shore as the ocean, insistent

32:24

and resolute, pulled her back.

32:27

Her brother, a foot taller and seventy

32:29

pounds heavier, tried to pull her up,

32:32

but the two of them were more than he could

32:34

manage. When she looks back,

32:36

Dr. Isaac is surprised by how

32:39

quickly she gave in to fatigue

32:41

and helplessness, recognizing

32:43

that she was severely outmatched,

32:46

figuring that it was the end. And

32:49

out of nowhere, a lifeguard

32:51

swam nimbly around the current and

32:54

pulled their exhausted, shaking,

32:56

humbled bodies to shore. There

32:59

have been moments in these past three years

33:02

when Dr. Isaac has felt like she

33:04

was drowning again. She

33:06

has visceral memories of the early

33:08

spring of 2020, when the

33:10

first patient with COVID pneumonia she

33:12

had cared for on the palliative care service

33:15

died in the ICU. Dr.

33:17

Isaac stood with the patient's family

33:20

outside the window of his room as

33:22

they said goodbye to him through

33:25

a speakerphone and felt the

33:27

tugging feeling of

33:28

being pulled under again.

33:31

Last winter,

33:33

Dr. Isaac took swimming lessons.

33:35

Her coach started gently, helping

33:38

Dr. Isaac gain comfort just being

33:40

in the water. Soon, the coach

33:43

coaxed Dr. Isaac to jump

33:45

in a deep water pool and notice

33:47

how little movement was truly

33:49

required to keep her head above

33:52

water. Head down, legs

33:54

strong, breath steady,

33:56

small adjustments to keep afloat.

34:01

In our images in clinical medicine, a

34:04

54-year-old woman with asthma and allergic

34:06

rhinitis presented to the emergency

34:08

department with a three-month history

34:10

of productive cough, dyspnea,

34:13

and constitutional symptoms. Peripheral

34:16

eosinophilia was noted.

34:18

CT of the chest showed upper

34:20

lobe predominant peripheral and

34:23

subpleural consolidations that

34:25

spared the perihilar region.

34:28

The radiographic pattern was described

34:31

as a photographic negative of

34:33

pulmonary edema, a finding

34:35

suggestive of chronic eosinophilic

34:38

pneumonia. In another

34:41

image, a 38-year-old man

34:43

with a history of corneal transplantation

34:46

presented with tearing, photophobia,

34:48

and reduced visual acuity in

34:51

his left eye. On slit-lamp

34:53

examination, a dendritic

34:55

ulcer was seen. A diagnosis

34:58

of herpes simplex dendritic keratitis

35:01

was made. Keratitis

35:04

is the most common form of ocular

35:06

herpes simplex infection. This

35:10

concludes our summary. Let us know

35:12

what you think about our podcast. Any

35:14

comments or suggestions may be sent

35:17

to audio at NEJM.org.

35:21

Thank you for listening.

Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features